30 years of experience

Founded in 1990, it is located in the Madrid region. It is 100% owned by Pharma Mar (following the merger by absorption of Zeltia by Pharma Mar). Our mission is to improve current methods of molecular diagnosis and genetic identification with reliable, automatic tools and in accordance with the highest quality standards.

Founded in 1990, it is located in the Madrid region. It is 100% owned by Pharma Mar (following the merger by absorption of Zeltia by Pharma Mar). Our mission is to improve current methods of molecular diagnosis and genetic identification with reliable, automatic tools and in accordance with the highest quality standards.

GENOMICA was founded in 1990 with the aim of providing a scientific response to a social need: to implement a reliable method for the identification of persons by DNA testing.

In only three years, the company completed the design and assembly of the DNA laboratories of the Spanish Civil Guard and Scientific Police. Subsequently, it carried out the same work in several countries in Latin America and Africa, while offering kinship analysis and genetic identification services.

GENOMICA is currently the leading company in genetic-forensic identification in Spain and the first accredited by the National Accreditation Entity according to the requirements of the ISO/IEC 17.025 standard for this type of testing.

International presence

In 2006, GENOMICA began a process of internationalization that has led the company to be present in 40 countries around the world.

Thanks to all this, GENOMICA is the leader in molecular diagnostics in Spain and a reference brand in the international arena.

Molecular diagnostics

Thanks to the experience accumulated by GENOMICA in DNA technology, the company went a step further to enter the world of molecular diagnostics. In the mid-1990s, the first products focused on the diagnosis of infectious diseases were marketed. In 2003, the development of CLART® began, an innovative technology based on low-density microarrays, which has made it possible to offer solutions in the diagnosis of infectious diseases. With this reliable, fast and robust technique, we believe we have responded to the fundamental needs of healthcare professionals in clinical diagnostics. CLART® is now being applied not only to microbiological diagnostics, but also to personalized medicine and oncology.